SAN DIEGO, CA – January 30, 2023 – AnaBios is pleased...Read More
WHAT WE DO
WHAT WE OFFER
AnaBios provides the unprecedented opportunity to de-risk drug development programs by assessing the safety and efficacy of drugs directly in human tissues and cells at the preclinical stage.
LEVERAGING HIGH QUALITY EX VIVO HUMAN TISSUE IN FUNCTIONAL ASSAYS
Enabling Clinical Success & Driving Translation from Bench to Bedside
AnaBios provides unparalleled access to human tissue and cells for drug discovery, creating the unprecedented opportunity to develop safer, more effective drugs while reducing time-to-market and clinical development costs.
In close partnership with organ donation organizations, hospitals and transplant centers, AnaBios has developed proprietary processes for functional ex vivo human platforms that redefine the concept of “First in Human” studies and bring true human biology to early pre-clinical discovery.
Our functional assays cover a wide breadth of cardiovascular, central nervous system (CNS) and peripheral nervous system (PNS) biology. Whether your team is looking to identify new therapeutics in heart failure, cardiovascular disorders, pain, itch, spinal cord ailments and other disease states, or looking to ensure cardiac and neuronal safety, let us bring native human biology into your pipeline at the earliest stages to ensure safety and efficacy while avoiding costly late-stage failures.
Similarly, if you are experiencing pipeline or clinical delays due to unanticipated adverse events, AnaBios can help fast track your programs for approval utilizing our human tissue platforms.
DISCOVER THE BENEFITS OF PREDICTIVE HUMAN DATA AT THE PRECLINICAL STAGE
HIGH QUALITY-HUMAN TISSUE & CELLS
HAVE MORE QUESTIONS?
To inquire about products, services and pricing, please go to the ‘Contact Us’ page by clicking the button below.